UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 195

Sortiert nach

shRNA library screening identifies nucleocytoplasmic transport as a mediator of BCR-ABL1 kinase-independent resistance

Blood, 2015-03, Vol.125 (11), p.1772-1781

2015

Volltextzugriff (PDF)

Similar expression profiles in CD34 + cells from chronic phase chronic myeloid leukemia patients with and without deep molecular responses to nilotinib

Oncotarget, 2018-04, Vol.9 (25), p.17889-17894

2018

Volltextzugriff (PDF)

BCR-ABL1 Compound Mutations Combining Key Kinase Domain Positions Confer Clinical Resistance to Ponatinib in Ph Chromosome-Positive Leukemia

Cancer cell, 2014-09, Vol.26 (3), p.428-442

2014

Volltextzugriff (PDF)

β-Catenin is required for intrinsic but not extrinsic BCR-ABL1 kinase-independent resistance to tyrosine kinase inhibitors in chronic myeloid leukemia

Leukemia, 2015-12, Vol.29 (12), p.2328-2337

2015

Volltextzugriff (PDF)

A coiled-coil mimetic intercepts BCR-ABL1 dimerization in native and kinase-mutant chronic myeloid leukemia

Leukemia, 2015-08, Vol.29 (8), p.1668-1675

2015

Volltextzugriff (PDF)

Direct Contact With Bone Marrow Stromal Cells Protects CML Progenitors From Imatinib Through Cytoplasmic Stabilization Of β-Catenin

Blood, 2013-11, Vol.122 (21), p.3982-3982

2013

Volltextzugriff (PDF)

The Tumor Suppressors, MS4A3 and G0S2, Are Downregulated in CML Cells with BCR-ABL1 Kinase-Independent Resistance

Blood, 2014-12, Vol.124 (21), p.1786-1786

2014

Volltextzugriff (PDF)

MS4A3 Improves Imatinib Response and Survival in BCR-ABL1 Primary TKI Resistance and in Blastic Transformation of Chronic Myeloid Leukemia

Blood, 2015-12, Vol.126 (23), p.14-14

2015

Volltextzugriff (PDF)

Design, Optimization, and Pre-Clinical Evaluation of Direct, Mechanism-Based STAT3 Inhibitors for Treating Myeloid Disorders

Blood, 2014-12, Vol.124 (21), p.4816-4816

2014

Volltextzugriff (PDF)

Next-Generation STAT3 Inhibitors As Targeted Therapeutics in Chronic Myeloid Leukemia

Blood, 2012-11, Vol.120 (21), p.2445-2445

2012

Volltextzugriff (PDF)

STAT3 Inhibition Synergizes with BCR-ABL1 Inhibition to Overcome Kinase-Independent TKI Resistance in Chronic Myeloid Leukemia (CML)

Blood, 2012-11, Vol.120 (21), p.31-31

2012

Volltextzugriff (PDF)

BP5-087, a Novel STAT3 Inhibitor, Combines With BCR-ABL1 Inhibition To Overcome Kinase-Independent Resistance In Chronic Myeloid Leukemia

Blood, 2013-11, Vol.122 (21), p.854-854

2013

Volltextzugriff (PDF)

An Unbiased shRNA Library Screen Identifies Nucleocytoplasmic Transport As a Potential Target For Treatment Of Chronic Myeloid Leukemia

Blood, 2013-11, Vol.122 (21), p.2707-2707

2013

Volltextzugriff (PDF)

Thwarted Belongingness and Perceived Burdensomeness: Construct Validity and Psychometric Properties of the Interpersonal Needs Questionnaire

Psychological assessment, 2012-03, Vol.24 (1), p.197-215

2012

Volltextzugriff (PDF)

Fearlessness About Death: The Psychometric Properties and Construct Validity of the Revision to the Acquired Capability for Suicide Scale

Psychological assessment, 2014-03, Vol.26 (1), p.115-126

2014

Volltextzugriff (PDF)

Psychometric Properties and U.S. National Norms of the Evidence-Based Practice Attitude Scale (EBPAS)

Psychological assessment, 2010-06, Vol.22 (2), p.356-365

2010

Volltextzugriff (PDF)

Evolutionary and mechanistic theories of aging

Annual review of entomology, 2005-01, Vol.50 (1), p.421-445

2005

Volltextzugriff (PDF)

Tracheal Basal Cells: A Facultative Progenitor Cell Pool

The American journal of pathology, 2010-07, Vol.177 (1), p.362-376

2010

Volltextzugriff (PDF)

Genetic influences on susceptibility to rheumatoid arthritis in African-Americans

Human molecular genetics, 2019-03, Vol.28 (5), p.858-874

2019

Volltextzugriff (PDF)

Outbreak of human monkeypox in Nigeria in 2017–18: a clinical and epidemiological report

The Lancet infectious diseases, 2019-08, Vol.19 (8), p.872-879

2019

Volltextzugriff (PDF)

Role of chronic stress and depression in periodontal diseases

Periodontology 2000, 2014-02, Vol.64 (1), p.127-138

2014

Volltextzugriff (PDF)

Expert Diagnosis of Plus Disease in Retinopathy of Prematurity From Computer-Based Image Analysis

JAMA ophthalmology, 2016-06, Vol.134 (6), p.651

2016

Volltextzugriff (PDF)

Association of Cutaneous Immune-Related Adverse Events With Increased Survival in Patients Treated With Anti-Programmed Cell Death 1 and Anti-Programmed Cell Death Ligand 1 Therapy

JAMA dermatology (Chicago, Ill.), 2022-02, Vol.158 (2), p.189

2022

Volltextzugriff (PDF)

1 – 25 von 195

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(177)
Mit Volltextzugriff
(171)

Publikationsform

Sprache

Englisch
(195)
Japanisch
(21)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

shRNA library screening identifies nucleocytoplasmic transport as a mediator of BCR-ABL1 kinase-independent resistance

Similar expression profiles in CD34 + cells from chronic phase chronic myeloid leukemia patients with and without deep molecular responses to nilotinib

BCR-ABL1 Compound Mutations Combining Key Kinase Domain Positions Confer Clinical Resistance to Ponatinib in Ph Chromosome-Positive Leukemia

Combined STAT3 and BCR-ABL1 inhibition induces synthetic lethality in therapy-resistant chronic myeloid leukemia

β-Catenin is required for intrinsic but not extrinsic BCR-ABL1 kinase-independent resistance to tyrosine kinase inhibitors in chronic myeloid leukemia

A coiled-coil mimetic intercepts BCR-ABL1 dimerization in native and kinase-mutant chronic myeloid leukemia

Direct Contact With Bone Marrow Stromal Cells Protects CML Progenitors From Imatinib Through Cytoplasmic Stabilization Of β-Catenin

The Tumor Suppressors, MS4A3 and G0S2, Are Downregulated in CML Cells with BCR-ABL1 Kinase-Independent Resistance

MS4A3 Improves Imatinib Response and Survival in BCR-ABL1 Primary TKI Resistance and in Blastic Transformation of Chronic Myeloid Leukemia

Next Generation Sequencing to Delineate the Mutational Landscape of Chronic Myelomonocytic Leukemia (CMML): Novel Disease Genes and Correlations with Survival

Design, Optimization, and Pre-Clinical Evaluation of Direct, Mechanism-Based STAT3 Inhibitors for Treating Myeloid Disorders

Next-Generation STAT3 Inhibitors As Targeted Therapeutics in Chronic Myeloid Leukemia

STAT3 Inhibition Synergizes with BCR-ABL1 Inhibition to Overcome Kinase-Independent TKI Resistance in Chronic Myeloid Leukemia (CML)

BP5-087, a Novel STAT3 Inhibitor, Combines With BCR-ABL1 Inhibition To Overcome Kinase-Independent Resistance In Chronic Myeloid Leukemia

An Unbiased shRNA Library Screen Identifies Nucleocytoplasmic Transport As a Potential Target For Treatment Of Chronic Myeloid Leukemia

Thwarted Belongingness and Perceived Burdensomeness: Construct Validity and Psychometric Properties of the Interpersonal Needs Questionnaire

Fearlessness About Death: The Psychometric Properties and Construct Validity of the Revision to the Acquired Capability for Suicide Scale

Psychometric Properties and U.S. National Norms of the Evidence-Based Practice Attitude Scale (EBPAS)

Evolutionary and mechanistic theories of aging

Tracheal Basal Cells: A Facultative Progenitor Cell Pool

Genetic influences on susceptibility to rheumatoid arthritis in African-Americans

Outbreak of human monkeypox in Nigeria in 2017–18: a clinical and epidemiological report

Role of chronic stress and depression in periodontal diseases

Expert Diagnosis of Plus Disease in Retinopathy of Prematurity From Computer-Based Image Analysis

Association of Cutaneous Immune-Related Adverse Events With Increased Survival in Patients Treated With Anti-Programmed Cell Death 1 and Anti-Programmed Cell Death Ligand 1 Therapy

Suchergebnisse filtern